Liver fibrosis is the most important predictor of mortality in nonalcoholic fatty liver disease
(NAFLD). Quantitative risk of mortality by fibrosis stage has not been systematically
evaluated. We aimed to quantify the fibrosis stage–specific risk of all‐cause and liver‐
related mortality in NAFLD. Through a systematic review and meta‐analysis, we identified
five adult NAFLD cohort studies reporting fibrosis stage–specific mortality (0‐4). Using
fibrosis stage 0 as a reference population, fibrosis stage–specific mortality rate ratios …